SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

76,957.27 -307.24
( -0.40%)

Global Indices

Nasdaq

53,569.16 -21.28
(-0.04%)

Dow Jones

7,731.77 -20.22
(-0.26%)

Hang Seng

66,147.06 -258.50
(-0.39%)

Nikkei 225

10,816.31 23.77
(0.22%)

Forex

USD-INR

95.48 0.22
(0.23%)

EUR-INR

111.24 0.16
(0.15%)

GBP-INR

129.74 0.04
(0.03%)

JPY-INR

0.60 0.00
(0.12%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Gufic BioSciences Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

509079

INE742B01025

66.2311355

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

GUFICBIO

55.8

4102.06

EPS(TTM)

Face Value()

Div & Yield %

7.33

0.02

Back

gufic biosciences ltd

Gufic BioSciences consolidated net profit declines 35.68% in the December 2025 quarter

Feb 14,2026

Net profit of Gufic BioSciences declined 35.68% to Rs 12.42 crore in the quarter ended December 2025 as against Rs 19.31 crore during the previous quarter ended December 2024. Sales rose 11.37% to Rs 231.41 crore in the quarter ended December 2025 as against Rs 207.79 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	231.41	207.79	11
OPM %	14.25	16.33	-
PBDT	25.41	30.88	-18
PBT	17.72	26.26	-33
NP	12.42	19.31	-36

76,957.27 -307.24 ( -0.40%)

53,569.16 -21.28 (-0.04%)

7,731.77 -20.22 (-0.26%)

66,147.06 -258.50 (-0.39%)

10,816.31 23.77 (0.22%)

95.48 0.22 (0.23%)

111.24 0.16 (0.15%)

129.74 0.04 (0.03%)

0.60 0.00 (0.12%)